Ranbaxy gets US FDA nod for glycopyrrolate tabs to treat peptic ulcer

Ranbaxy Laboratories Limited (RLL), has received approval from the US Food and Drug Administration (US FDA) to manufacture and market glycopyrrolate tablets USP, 1 mg and 2 mg. The Office of Generic Drugs, US FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Robinul 1 mg and Robinul Forte tablets, 2 mg, respectively, of Sciele Pharma, Inc. 

The total annual market sales for glycopyrrolate tablets were $26 million. glycopyrrolate tablets are indicated for use as adjunctive therapy in the treatment of peptic ulcer.

Comments

Post a Comment

Popular posts from this blog

Trump wants more mental health care; Alabama says it's trying

Image
Trump wants more mental health care; Alabama says it's trying    AL.com Budget undercuts Trump focus on mental health, school safety    Yahoo News Mental health awareness license plates offered by New York State DMV    Buffalo News Trump wants to 'tackle the difficult issue of mental health?' He should put his money where his mouth is.    Washington Post Full coverage
Read more

Smokefree Mumbai campaign responds to recent study by BCM, Houston that claims smoking create stronger memory

It has been scientifically proven, time and again, that smoking leads to memory decline. Extensive research conducted by several reputed institutions, including the University College of London (UCL)(2003) the Erasmus Medical Centre, Netherlands(2008) and the University of Minnesota(2009) stand testimony to this long-standing fact. Yet, a study conducted recently, by the Baylor College of Medicine (BCM), Houston, claims smoking creates stronger memories.   Speaking on the issue, Dr Surendra Shastri, chairman of the Smokefree Mumbai campaign said, "The article from the Baylor College of Medicine published in media looks like a typical, out of context 'cut and paste' report of the original scientific article engineered by the tobacco lobby. Far from improving memory, a more recent publication (August 19, 2009) in the Journal of Neurology, Neurosurgery and Psychiatry, by Alvaro Alonso, MD, and colleagues from the University of Minnesota in Minneapolis, reported that curre...
Read more